Atovaquone
CAS No. 95233-18-4
Atovaquone ( BW 566C; BW 556C-80 )
Catalog No. M16808 CAS No. 95233-18-4
Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 39 | In Stock |
|
25MG | 73 | In Stock |
|
50MG | 132 | In Stock |
|
100MG | 196 | In Stock |
|
200MG | 291 | In Stock |
|
500MG | 489 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAtovaquone
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
-
DescriptionAtovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
-
SynonymsBW 566C; BW 556C-80
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorDHODH; Cytochrome b
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number95233-18-4
-
Formula Weight366.84
-
Molecular FormulaC22H19ClO3
-
Purity>98%(HPLC)
-
SolubilityDMSO: 5 mg/mL (13.62 mM)
-
SMILESO=C1C([C@H]2CC[C@H](C3=CC=C(Cl)C=C3)CC2)=C(O)C(C4=C1C=CC=C4)=O
-
Chemical Nametrans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Winter RW, et al. Exp Parasitol. 2008 Apr; 118(4):487-97.
molnova catalog
related products
-
6PGD-IN-S3
6PGD-IN-S3 is an inhibitor of 6-phosphogluconate dehydrogenase (6PGD).
-
Octanoic acid
CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.
-
hDHODH-IN-5
hDHODH-IN-5 is an inhibitor of human dihydroorotate dehydrogenase.